Amnesia

Clearwater Living's Jill Zimmerman takes on Expanded Role as Director of Resident Engagement and Wellbeing

Retrieved on: 
Tuesday, February 13, 2024

NEWPORT BEACH, Calif., Feb. 13, 2024 /PRNewswire/ -- Clearwater Living® , a real estate and property management company dedicated to the ownership, operation and development of high-quality senior living communities, announced today that Jill Zimmerman will be taking on new responsibilities in an expanded role as director of resident engagement and wellbeing.

Key Points: 
  • NEWPORT BEACH, Calif., Feb. 13, 2024 /PRNewswire/ -- Clearwater Living® , a real estate and property management company dedicated to the ownership, operation and development of high-quality senior living communities, announced today that Jill Zimmerman will be taking on new responsibilities in an expanded role as director of resident engagement and wellbeing.
  • Zimmerman is a certified grief coach that joined Clearwater Living in 2019 as the lifestyle director for Clearwater at Sonoma Hills.
  • Clearwater Living believes purposeful connections with others, shared experiences and community involvement is integral to health and wellbeing.
  • Diverse programs, amenities, and events promote physical activity, stimulate the mind, encourage social engagement and provide an environment that's perfect for effortless living.

Health E-Commerce® partners with Lofta, making CPAP devices available on FSA Store® and HSA Store®

Retrieved on: 
Tuesday, February 13, 2024

DALLAS, Feb. 13, 2024 /PRNewswire-PRWeb/ -- It's estimated that more than 30 million people in the United States have sleep apnea and 33 million use a CPAP machine to manage this condition. Untreated, sleep apnea can contribute to a number of serious health conditions, including heart disease, memory loss, depression, and headaches. However, thanks to a new partnership between Health-E Commerce® and Lofta, individuals with sleep apnea can now purchase Lofta sleep apnea devices with tax-free flexible spending account (FSA) or health savings account (HSA) funds at FSA Store® and HSA Store®.

Key Points: 
  • Untreated, sleep apnea can contribute to a number of serious health conditions, including heart disease, memory loss, depression, and headaches.
  • However, thanks to a new partnership between Health-E Commerce® and Lofta , individuals with sleep apnea can now purchase Lofta sleep apnea devices with tax-free flexible spending account (FSA) or health savings account (HSA) funds at FSA Store® and HSA Store® .
  • We're immensely proud of our new partnership with Lofta, which allows FSA Store and HSA Store to meet the changing needs of account holders, improve chronic condition management, and support whole-person health.
  • The Lofta team believes this partnership with Health E-Commerce will advance their mission to bring good sleep to those who need it.

Ameriprise Financial, Along with its Employees and Advisors, Donated More than $16.5 Million in 2023

Retrieved on: 
Monday, February 12, 2024

Ameriprise Financial, Inc. (NYSE: AMP) and its employees and advisors donated more than $16.5 million through corporate grants, individual donations and gift matching in 2023.

Key Points: 
  • Ameriprise Financial, Inc. (NYSE: AMP) and its employees and advisors donated more than $16.5 million through corporate grants, individual donations and gift matching in 2023.
  • Throughout the year, Ameriprise employees and advisors logged nearly 63,000 volunteer hours supporting causes and organizations that help build strong communities.
  • In addition, the company continued its longstanding partnership with Feeding America, providing more than 124 million meals to people facing hunger.
  • Ameriprise Bank also provided liquidity to the Twin Cities area residential mortgage market with a $10 million investment in a low and moderate-income mortgage-backed security in 2023.

This is how tobacco damages our cells

Retrieved on: 
Friday, February 9, 2024

With the countless studies available today on the effects of tobacco use, we should have no trouble convincing ourselves and others of how harmful it is.

Key Points: 
  • With the countless studies available today on the effects of tobacco use, we should have no trouble convincing ourselves and others of how harmful it is.
  • The cells that make up our tissues, organs and body systems are sensitive to the effects of external toxic agents, many of which can be found in tobacco.
  • Many smokers not only accept this, but also ignore the serious danger it poses to the people around them.

Initial effects in the mouth and pharynx

  • When tobacco smoke enters our body, the first cells to receive it are in the mouth, nose and throat.
  • These effects on the immune system are also linked to a higher likelihood of developing cancer.
  • We also cannot forget that tobacco smoke robs us of our sense of taste and smell, leaving an almost continuous bitter taste in the mouth.

Lung damage

  • Furthermore, due to the direct damage caused by tobacco on the tissue that maintains the structure of the lungs, the bronchi and bronchioles become blocked, generating symptoms similar to suffocation.
  • As if that were not enough, people with COPD are also more likely to develop cardiovascular disease, and lung cancer.

Black tar and macrophages

  • We can cast our minds back to the previous image of my father’s pipe, black and sticky with tar.
  • It so happens that the lungs are rich in macrophages – special cells that play a key role in our immune systems by reacting to attacks, producing inflammatory responses.
  • These cells end up ingesting the tar from tobacco, and they eventually die loaded with this substance which builds up and gives a smoker’s lungs their characteristic blackened appearance.

Nicotine’s effects on neurons: dependence and addiction

  • As with any other compound that stimulates neurotransmitter receptors, permanent stimulation desensitises neurons.
  • This means that the neurons reduce the number of receptors, or change their sensitivity to the stimulant.
  • This desensitisation process can lead not only to nicotine dependence, but also to other diseases such as memory loss.


Guillermo López Lluch is a member of the Spanish Society of Cell Biology, the Spanish Society of Biochemistry and Molecular Biology, the Spanish Society of Geriatrics and Gerontology, the Society for Free Radical Research and the International Coenzyme Q10 Association. The research carried out by the author is financed by public funds from the Spanish Government or the Autonomous Government of Andalusia.

Heart attacks, cancer, dementia, premature deaths: 4 essential reads on the health effects driving EPA’s new fine particle air pollution standard

Retrieved on: 
Thursday, February 8, 2024

These minute particles can penetrate deeply into the body and have been linked to many serious illnesses.

Key Points: 
  • These minute particles can penetrate deeply into the body and have been linked to many serious illnesses.
  • The new rule sets an annual limit of 9 micrograms per cubic meter of air, down from the previous level of 12 micrograms.
  • Under the Clean Air Act, the EPA is required to set air pollution standards at levels that protect public health.

1. An alarming array of health effects

  • Subsequent research has linked fine particulates to a much broader range of health effects.
  • They termed fine particle pollution an urgent global health threat.
  • “Developed countries have made progress in reducing particulate air pollution in recent decades, but much remains to be done to further reduce this hazard,” they observed.

2. Aging the brain

  • Medical researchers are looking closely at air pollution as a possible accelerator of brain aging.
  • “When we compared the brain scans of older women from locations with high levels of PM2.5 to those with low levels, we found dementia risk increased by 24% over the five years,” Chen wrote.
  • More alarmingly, “(T)hese Alzheimer’s-like brain changes were present in older women with no memory problems,” Chen noted.

3. Disadvantaged communities have dirtier air

  • As researchers in environmental justice have shown, facilities such as factories and refineries often are concentrated in low-income neighborhoods and communities of color.
  • This means that these areas are exposed to higher pollution levels and face heavier related health burdens.
  • Regulations put in place under the Clean Air Act have greatly reduced levels of harmful air pollutants across the U.S. over the past 50 years.
  • “In 1981 PM2.5 concentrations in the most polluted 10% of census tracts averaged 34 micrograms per cubic meter,” the authors reported.

4. Fine particle pollution hurts wildlife too

  • Like the proverbial canaries in coal mines, wild animals can show effects of exposure to pollution that offer broader warnings.
  • Cornell University conservation biologist Wendy M. Erb was studying wild orangutans in Indonesian Borneo when that island suffered large-scale wildfires.
  • “Using passive acoustic monitoring to study vocally active indicator species, like orangutans, could unlock critical insights into wildfire smoke’s effects on wildlife populations worldwide,” she observed.

Do one in six Indians over 59 really have a mild brain disorder, as a new study suggests?

Retrieved on: 
Thursday, February 8, 2024

A new study, published in PLOS One, suggests that the prevalence of dementia in India is higher than previously thought.

Key Points: 
  • A new study, published in PLOS One, suggests that the prevalence of dementia in India is higher than previously thought.
  • Dementia is considered a major neurocognitive disorder, while mild cognitive impairment, a common early stage of dementia, a minor neurocognitive disorder.
  • The study results showed that nearly one-sixth (17.6%) of people over 59 in India have a mild neurocognitive disorder, while 7.2% have a major neurocognitive disorder.
  • Mild cognitive impairment and dementia are commonly based on performance on cognitive tests and whether cognitive changes affect everyday activities.
  • For mild cognitive impairment, people will have mild cognitive changes, but they do not affect their everyday activities.

Shortcomings

  • Despite cognition and everyday activity being key to dementia diagnostics worldwide, they have significant shortcomings, in particular for assessments in developing countries, such as India.
  • For the current study, nearly half of their participants had either no formal education or were illiterate.
  • But what else can we do to determine if someone is either at risk or has dementia?
  • Read more:
    Playing a musical instrument or singing in a choir may boost your brain – new study


Michael Hornberger does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Talkiatry Launches Geriatric Psychiatry Services to Support Aging Population

Retrieved on: 
Tuesday, January 30, 2024

Talkiatry is committed to providing greater access to quality, specialized care for the often-overlooked aging patient population through its easy-to-navigate telehealth platform and team of board-certified geriatric psychiatrists.

Key Points: 
  • Talkiatry is committed to providing greater access to quality, specialized care for the often-overlooked aging patient population through its easy-to-navigate telehealth platform and team of board-certified geriatric psychiatrists.
  • "Geriatric care, especially geriatric psychiatry, needs to be both specific and broad, as there are so many ways a person can age.
  • Talkiatry's geriatric psychiatry services cater and attend to all aging patients," said Georgia Gaveras, DO, co-founder and Chief Medical Officer, Talkiatry.
  • For the geriatric patient population, initial appointments are extended from 60 to 75 minutes, allowing more time for psychiatrists to establish rapport.

U.S. Company Announces Revolutionary AI Treatment for Alzheimer's at the Microcaps Conference

Retrieved on: 
Tuesday, January 23, 2024

Alzheimer's Treatment Centers of America (ATCA) only treats Alzheimer's, Dementia, Cognitive Impairment and Brain Fog from Long COVID, using Artificial Intelligence combined with Personalized Precision Medicine. In the study of its AI protocol, 75% of the patients had no further decline in their mild cognitive impairment.

Key Points: 
  • ATCA's mission to treat Alzheimer's, dementia, memory loss and brain fog from Long COVID that will reshape healthcare for the aging population.
    "
  • Alzheimer's Treatment Centers of America is not a start-up; it is a roll out and it is ready to scale.
  • Alzheimer's Treatment Centers of America uses Expert Artificial Intelligence (AI) technology with AI tools to create personalized care plans aimed at helping physicians improve patient care while also satisfying cognitive care guidelines.
  • Alzheimer's Treatment Centers of America has invested $1.5 million in onsite treatment tools and modalities, a pharma-grade nutraceutical store onsite, along with a 20-chair infusion center.

David Pyrce Appointed as New CEO of Cognigenics, Inc.

Retrieved on: 
Tuesday, January 16, 2024

In conjunction with this appointment, John Mee, the current CEO, will continue his journey with Cognigenics as the President, transitioning to the role of Founder and President.

Key Points: 
  • In conjunction with this appointment, John Mee, the current CEO, will continue his journey with Cognigenics as the President, transitioning to the role of Founder and President.
  • View the full release here: https://www.businesswire.com/news/home/20240113201047/en/
    With an illustrious career that spans various facets of the healthcare and capital markets sectors, David Pyrce is recognized for his comprehensive expertise.
  • "I am thrilled to join Cognigenics, a company at the forefront of genetic neuroengineering and mental health solutions," said David Pyrce.
  • With Mr. Pyrce at the helm, the company is set to continue its trajectory as a leader in cognitive health solutions, improving lives with cutting-edge genetic medicine.

Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia

Retrieved on: 
Friday, January 12, 2024

SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Today marks a turning point in the battle against Alzheimer's disease as Darmiyan, Inc., a leading company in brain health innovation announces the FDA's approval of its first-in-class (De Novo) clinical test, BrainSee. This approval marks a pivotal advancement in brain health and opens the door to untapped market potential in brain disease diagnosis and management.

Key Points: 
  • Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia.
  • This approval marks a pivotal advancement in brain health and opens the door to untapped market potential in brain disease diagnosis and management.
  • BrainSee addresses a critical unmet need for over 10 million Americans and over 100 million patients worldwide grappling with aMCI.
  • It stands out for its prognostic accuracy, patient convenience, same-day test results and seamless integration into the clinical workflow.